PARSONS CAPITAL MANAGEMENT INC/RI – Relmada Therapeutics, Inc. Transaction History
PARSONS CAPITAL MANAGEMENT INC/RI portfolio value:
$18.65M
portfolio value
PARSONS CAPITAL MANAGEMENT INC/RI quarter portfolio value change:
+94.94%
quarter
Relmada Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 25 shares | 9.08M | $37.02 | 503.80K |
| Q2 2022 | share | Increase | +0.14% | 700 shares | -4.01M | $18.99 | 503.77K |
| Q1 2022 | share | Decrease | -0.07% | -336 shares | 2.23M | $26.99 | 503.07K |
| Q4 2021 | share | Increase | +6.44% | 30.43K shares | -1.05M | $21.71 | 503.41K |
| Q3 2021 | share | Increase | +5.01% | 22.56K shares | -2.02M | $26.21 | 472.97K |
| Q2 2021 | share | Decrease | -0.22% | -1K shares | -1.47M | $32.01 | 450.41K |
| Q1 2021 | share | Decrease | -0.04% | -200 shares | 1.41M | $35.21 | 451.41K |
| Q4 2020 | share | Decrease | -0.77% | -3.52K shares | -2.63M | $32.07 | 451.61K |
| Q3 2020 | share | Increase | +0.23% | 1.05K shares | -3.19M | $37.62 | 455.13K |
| Q2 2020 | share | Increase | +6.70% | 28.51K shares | 5.80M | $44.75 | 454.08K |
| Q1 2020 | share | Increase | +15.98% | 58.64K shares | 206K | $34.11 | 425.57K |
| Q4 2019 | share | Increase | 0.00% | 366.93K shares | 14.31M | $39 | 366.93K |